希毅医学是一家以全球临床试验为业务核心的CRO公司,为中国生物医药与医疗器械企业提供定制化出海解决方案,服务内容包括出海策略咨询、海外临床试验申请与实施、海外产品注册及商业化布局。自创立起,希毅医学已成功帮助超过50个医药和器械项目在海外顺利落地,为客户累计带来超过160亿人民币的利润。目前,希毅医学自有海外临床团队超100人,合作专家超2000位,签约海外合作医院超100个,覆盖欧盟、北美、澳新、东南亚、日韩、中东、非洲等地区。
MDCE is a CRO with global clinical trials as its core business. MDCE provides customized solutions for Chinese biopharmaceutical and medical device companies to go global. MDCE’s services include consulting and strategy development of overseas clinical trials, overseas clinical trial management and operations, overseas product registration and commercialization. Since its establishment, MDCE has successfully helped over 50 biopharmaceutical and medical device projects land overseas, generating accumulated overseas profits exceeding 16 billion RMB for its clients. Currently, MDCE has its own overseas clinical trial team of over 100 members, collaborating with over 2,000 experts and partnering with more than 100 well-known overseas hospitals across the EU, North America, Australia, New Zealand, Southeast Asia, Japan, South Korea, the Middle East, Africa, and other regions.